Dhampur Bio Organics Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 11, 2025. Further, the company has informed the Exchange regarding voting results.
DBOL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dhampur Bio Organics Limited held its 5th Annual General Meeting on July 11, 2025, via video conferencing, and submitted the voting results and scrutinizer's report to the exchanges on July 14, 2025. All 8 resolutions were passed with overwhelming shareholder support, with approval percentages above 99.98% on every item. Key approvals included the adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, declaration of a final dividend of Rs. 1.25 per equity share (12.50%), and re-appointment of Mr. Vijay Kumar Goel (Chairman & Executive Director), Mr. Gautam Goel (Managing Director & CEO), and Mr. Sandeep Kumar (Whole-Time Director) along with their remuneration. The company also received approval for cost auditor remuneration for FY 2025-26 and the appointment of a secretarial auditor. Mr. Saket Sharma of GSK & Associates served as scrutinizer, and out of 50,062 shareholders on record, 85 attended through video conferencing.
Shareholders are set to receive a final dividend of Rs. 1.25 per share for FY25, providing a direct cash return. The near-unanimous approval across all resolutions, including the re-appointment of key promoter-family directors, signals strong governance continuity and no visible dissent, which is generally neutral-to-positive for investor confidence.